378 related articles for article (PubMed ID: 18980046)
21. Management of Acne Vulgaris: A Review.
Eichenfield DZ; Sprague J; Eichenfield LF
JAMA; 2021 Nov; 326(20):2055-2067. PubMed ID: 34812859
[TBL] [Abstract][Full Text] [Related]
22. Acne vulgaris.
Wilson BB
Prim Care; 1989 Sep; 16(3):695-712. PubMed ID: 2529576
[TBL] [Abstract][Full Text] [Related]
23. A single-center, randomized double-blind, parallel-group study to examine the safety and efficacy of 3mg drospirenone/0.02 mg ethinyl estradiol compared with placebo in the treatment of moderate truncal acne vulgaris.
Palli MB; Reyes-Habito CM; Lima XT; Kimball AB
J Drugs Dermatol; 2013 Jun; 12(6):633-7. PubMed ID: 23839178
[TBL] [Abstract][Full Text] [Related]
24. A randomized controlled trial of a low-dose combined oral contraceptive containing 3 mg drospirenone plus 20 microg ethinylestradiol in the treatment of acne vulgaris: lesion counts, investigator ratings and subject self-assessment.
Maloney JM; Dietze P; Watson D; Niknian M; Lee-Rugh S; Sampson-Landers C; Korner P
J Drugs Dermatol; 2009 Sep; 8(9):837-44. PubMed ID: 19746676
[TBL] [Abstract][Full Text] [Related]
25. New developments in hormonal therapy for acne.
Tan JK
Skin Therapy Lett; 2007 Sep; 12(7):1-3. PubMed ID: 17940710
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long-term treatment of hirsutism.
Batukan C; Muderris II
Fertil Steril; 2006 Feb; 85(2):436-40. PubMed ID: 16595223
[TBL] [Abstract][Full Text] [Related]
27. Isotretinoin: new therapy for severe acne.
Perry MD; McEvoy GK
Clin Pharm; 1983; 2(1):12-9. PubMed ID: 6192964
[TBL] [Abstract][Full Text] [Related]
28. YAZ in the treatment of premenstrual dysphoric disorder.
Rapkin AJ
J Reprod Med; 2008 Sep; 53(9 Suppl):729-41. PubMed ID: 18980045
[TBL] [Abstract][Full Text] [Related]
29. Adolescent female acne: etiology and management.
Olutunmbi Y; Paley K; English JC
J Pediatr Adolesc Gynecol; 2008 Aug; 21(4):171-6. PubMed ID: 18656070
[TBL] [Abstract][Full Text] [Related]
30. Common and alternate oral antibiotic therapies for acne vulgaris: a review.
Amin K; Riddle CC; Aires DJ; Schweiger ES
J Drugs Dermatol; 2007 Sep; 6(9):873-80. PubMed ID: 17941358
[TBL] [Abstract][Full Text] [Related]
31. Acne vulgaris in childhood. Pathogenesis and management.
Yonkosky DM; Pochi PE
Dermatol Clin; 1986 Jan; 4(1):127-36. PubMed ID: 2941198
[TBL] [Abstract][Full Text] [Related]
32. Effects of two estroprogestins containing ethynilestradiol 30 microg and drospirenone 3 mg and ethynilestradiol 30 microg and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations.
Lello S; Primavera G; Colonna L; Vittori G; Guardianelli F; Sorge R; Raskovic D
Gynecol Endocrinol; 2008 Dec; 24(12):718-23. PubMed ID: 19172543
[TBL] [Abstract][Full Text] [Related]
33. The duration of response to norgestimate and ethinyl estradiol in the treatment of acne vulgaris.
Olson WH; Lippman JS; Robisch DM
Int J Fertil Womens Med; 1998; 43(6):286-90. PubMed ID: 9920537
[TBL] [Abstract][Full Text] [Related]
34. Acne treatment with a new estroprogestinic biphasic combination containing desogestrel.
Falsetti L
Acta Eur Fertil; 1991; 22(5):283-6. PubMed ID: 1845752
[No Abstract] [Full Text] [Related]
35. Managing acne vulgaris effectively.
Goodman G
Aust Fam Physician; 2006 Sep; 35(9):705-9. PubMed ID: 16969442
[TBL] [Abstract][Full Text] [Related]
36. Expert committee recommendations for acne management.
Zaenglein AL; Thiboutot DM
Pediatrics; 2006 Sep; 118(3):1188-99. PubMed ID: 16951015
[TBL] [Abstract][Full Text] [Related]
37. Advances and perspectives in acne therapy.
Jansen T; Plewig G
Eur J Med Res; 1997 Aug; 2(8):321-34. PubMed ID: 9262484
[TBL] [Abstract][Full Text] [Related]
38. Use of drospirenone/ethinyl estradiol (DRSP/EE) among women with acne reduces acne treatment-related resources.
Joish VN; Boklage S; Lynen R; Schmidt A; Lin J
J Med Econ; 2011; 14(6):681-9. PubMed ID: 21892859
[TBL] [Abstract][Full Text] [Related]
39. An expert view on the treatment of acne with systemic antibiotics and/or oral isotretinoin in the light of the new European recommendations.
Dréno B; Bettoli V; Ochsendorf F; Perez-Lopez M; Mobacken H; Degreef H; Layton A
Eur J Dermatol; 2006; 16(5):565-71. PubMed ID: 17101480
[TBL] [Abstract][Full Text] [Related]
40. New and emerging treatments in dermatology: acne.
Katsambas A; Dessinioti C
Dermatol Ther; 2008; 21(2):86-95. PubMed ID: 18394082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
